Overview
Optimal Treatment of MRSA Throat Carriers
Status:
Recruiting
Recruiting
Trial end date:
2022-12-30
2022-12-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of this study is to investigate the optimal way to treat MRSA throat carriers.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Hvidovre University HospitalTreatments:
Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Criteria
Inclusion Criteria:- Age ≥ 18 years
- MRSA carriage in the throat after first topical decolonization treatment (regardless
of previous swab results)
- Has completed one standard topical decolonization treatment
Exclusion Criteria:
- Pregnant or lactating woman
- Sexually active women in the reproductive age that do not use approved contraceptives
(appendix 4)
- Cannot read or speak Danish (the written participant information is in Danish)
- Skin infection or other active infections
- Activity in skin diseases such as eczema or psoriasis.
- MRSA isolate resistant to clindamycin (defined by inhibition zone size < 22 mm using
disk diffusion methodology) or resistant to mupirocin
- Allergy to clindamycin, chlorhexidine or mupirocin
- Taking medications that interact with clindamycin according to the medicine
information leaflet.
- MRSA active antibiotic treatment within 7 days before inclusion in the study or during
study period
- Followed by specialist due to liver disease
- Severe overweight (BMI > 35) or weight < 50 kg
- Indwelling percutaneous permanent devices such as intravenous catheters or urinary
tract catheters
- Daily contact with pigs or minks (decolonization therapy is generally not offered,
according to The National Board of Health)
- Nursing home resident or health care worker (they have a more frequent control swab
regime)
- Not being capable of completing another treatment successfully
- MRSA positive household members younger than 2 years (MRSA positive children below 2
years of age and their household members are generally not offered decolonization
treatment according to The National Board of Health)
- MRSA positive household members, where it is judged that further decolonization
attempts are not indicated